These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 9377072)

  • 21. Differential modulation of adhesion markers with ex vivo expansion of human umbilical CD34+ progenitor cells.
    Reems JA; Mielcarek M; Torok-Storb B
    Biol Blood Marrow Transplant; 1997 Aug; 3(3):133-41. PubMed ID: 9310190
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Porcine brain microvascular endothelial cells support the in vitro expansion of human primitive hematopoietic bone marrow progenitor cells with a high replating potential: requirement for cell-to-cell interactions and colony-stimulating factors.
    Davis TA; Robinson DH; Lee KP; Kessler SW
    Blood; 1995 Apr; 85(7):1751-61. PubMed ID: 7535587
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cycling status of CD34+ cells mobilized into peripheral blood of healthy donors by recombinant human granulocyte colony-stimulating factor.
    Lemoli RM; Tafuri A; Fortuna A; Petrucci MT; Ricciardi MR; Catani L; Rondelli D; Fogli M; Leopardi G; Ariola C; Tura S
    Blood; 1997 Feb; 89(4):1189-96. PubMed ID: 9028941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proliferative response of human marrow myeloid progenitor cells to in vivo treatment with granulocyte colony-stimulating factor alone and in combination with interleukin-3 after autologous bone marrow transplantation.
    Lemoli RM; Fortuna A; Fogli M; Gherlinzoni F; Rosti G; Catani L; Gozzetti A; Miggiano MC; Tura S
    Exp Hematol; 1995 Dec; 23(14):1520-6. PubMed ID: 8542941
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Growth factors and cytokines upregulate gelatinase expression in bone marrow CD34(+) cells and their transmigration through reconstituted basement membrane.
    Janowska-Wieczorek A; Marquez LA; Nabholtz JM; Cabuhat ML; Montaño J; Chang H; Rozmus J; Russell JA; Edwards DR; Turner AR
    Blood; 1999 May; 93(10):3379-90. PubMed ID: 10233890
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ex vivo expansion of CD34+ umbilical cord blood cells in a defined serum-free medium (QBSF-60) with early effect cytokines.
    Qiu L; Meagher R; Welhausen S; Heye M; Brown R; Herzig RH
    J Hematother Stem Cell Res; 1999 Dec; 8(6):609-18. PubMed ID: 10645768
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of recombinant human thrombopoietin alone and in combination with erythropoietin and early-acting cytokines on human mobilized purified CD34+ progenitor cells cultured in serum-depleted medium.
    Birkmann J; Oez S; Smetak M; Kaiser G; Kappauf H; Gallmeier WM
    Stem Cells; 1997; 15(1):18-32. PubMed ID: 9007219
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Beyond CD34+ cell dose: impact of method of peripheral blood hematopoietic stem cell mobilization (granulocyte-colony-stimulating factor [G-CSF], G-CSF plus plerixafor, or cyclophosphamide G-CSF/granulocyte-macrophage [GM]-CSF) on number of colony-forming unit-GM, engraftment, and Day +100 hematopoietic graft function.
    Alexander ET; Towery JA; Miller AN; Kramer C; Hogan KR; Squires JE; Stuart RK; Costa LJ
    Transfusion; 2011 Sep; 51(9):1995-2000. PubMed ID: 21392017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative study of the phenotype and proliferative capacity of peripheral blood (PB) CD34+ cells mobilized by four different protocols and those of steady-phase PB and bone marrow CD34+ cells.
    To LB; Haylock DN; Dowse T; Simmons PJ; Trimboli S; Ashman LK; Juttner CA
    Blood; 1994 Nov; 84(9):2930-9. PubMed ID: 7524760
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Serum-free ex vivo expansion of CD34(+) hematopoietic progenitor cells.
    Möbest D; Mertelsmann R; Henschler R
    Biotechnol Bioeng; 1998 Nov; 60(3):341-7. PubMed ID: 10099437
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pegylated granulocyte colony-stimulating factor mobilizes CD34+ cells with different stem and progenitor subsets and distinct functional properties in comparison with unconjugated granulocyte colony-stimulating factor.
    Bruns I; Steidl U; Fischer JC; Czibere A; Kobbe G; Raschke S; Singh R; Fenk R; Rosskopf M; Pechtel S; von Haeseler A; Wernet P; Tenen DG; Haas R; Kronenwett R
    Haematologica; 2008 Mar; 93(3):347-55. PubMed ID: 18268278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biological characterization of CD34+ cells mobilized into peripheral blood.
    Lemoli RM; Tafuri A; Fortuna A; Catani L; Rondelli D; Ratta M; Tura S
    Bone Marrow Transplant; 1998 Dec; 22 Suppl 5():S47-50. PubMed ID: 9989890
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Analysis of peripheral blood CD34+ cells mobilized with granulocyte colony-stimulating factor (G-CSF) using a long-term culture system.
    Suzuki T; Muroi K; Amemiya Y; Miura Y
    Bone Marrow Transplant; 1998 Apr; 21(8):751-7. PubMed ID: 9603397
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effect of addition of FLT-3 ligand and megakaryocyte growth and development factor on hemopoietic cells in serum-free conditions.
    Rossi B; Zanolin E; Vincenzi C; Diani F; Pizzolo G; de Wynter E; Nadali G
    Stem Cells Dev; 2004 Aug; 13(4):362-71. PubMed ID: 15345130
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increase in peripheral blood megakaryocyte progenitors following cancer therapy with high-dose cyclophosphamide and hematopoietic growth factors.
    Siena S; Bregni M; Bonsi L; Sklenar I; Bagnara GP; Bonadonna G; Gianni AM
    Exp Hematol; 1993 Nov; 21(12):1583-90. PubMed ID: 7691640
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization of enriched CD34+ cells from healthy volunteers and those from patients treated with chemotherapy plus granulocyte colony-stimulating factor (G-CSF).
    Suzuki T; Muroi K; Tomizuka H; Amemiya Y; Miura Y
    Stem Cells; 1995 May; 13(3):273-80. PubMed ID: 7542113
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fetal bone marrow CD34+CD41+ cells are enriched for multipotent hematopoietic progenitors, but not for pluripotent stem cells.
    Murray LJ; Mandich D; Bruno E; DiGiusto RK; Fu WC; Sutherland DR; Hoffman R; Tsukamoto A
    Exp Hematol; 1996 Feb; 24(2):236-45. PubMed ID: 8641347
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Promotion of differentiation and proliferation of peripheral blood CD34+ cells in vitro by G-CSF.
    Xu J; Arimori S; Kobayashi N; Nakamura Y; Takei M; Arahira Y
    Chin Med J (Engl); 1996 May; 109(5):372-5. PubMed ID: 9208494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.
    Ho AD; Young D; Maruyama M; Corringham RE; Mason JR; Thompson P; Grenier K; Law P; Terstappen LW; Lane T
    Exp Hematol; 1996 Nov; 24(13):1460-8. PubMed ID: 8950228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of cytokines for expansion of the megakaryocyte and granulocyte lineages.
    LaIuppa JA; Papoutsakis ET; Miller WM
    Stem Cells; 1997; 15(3):198-206. PubMed ID: 9170211
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.